Description
| Suitable for |   |
|---|---|
| Product Type | Water soluble powder |
| Content |
Tilmicosin (as phosphate) 100g / kg |
| Packing | 500g, 25kg |
| Suitable for | |
|---|---|
| Product Type | Water soluble powder |
| Content |
Tilmicosin (as phosphate) 100g / kg |
| Packing | 500g, 25kg |
Tilmicosin is a broad-spectrum semi-synthetic bactericidal macrolide antibiotic synthesized from tylosin. It has an antibacterial spectrum that is predominantly effective against Mycoplasma, Pasteurella and Haemophilus spp. and various Gram-positive organisms such as Corynebacterium spp. It is believed to affect bacterial protein synthesis through binding to 50S ribosomal subunits. Cross-resistance between tilmicosin and other macrolide antibiotics has been observed. Following oral administration, tilmicosin is excreted mainly via the bile into the faeces, with a small proportion being excreted via the urine.
EM-Micofeed is indicated for the control and treatment of respiratory infections associated with tilmicosin-susceptible micro-organisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus pleuropneumoniae, Actinomyces pyogenes and Mannheimia haemolytica in calves, chickens, turkeys and swine.
8mg to 16mg of Em-Micofeed 10% per kg body weight per day, corresponding to 2kg to 4kg / ton of feed for 15 days.
